Trigeminal nerve block as an adjuvant in general anesthesia for facial surgery due to squamous cell neoplasm of the ethmoid sinus: A case report

Abstract

trigeminal nerve, is highlighted as a pillar of multimodal analgesia in craniofacial surgery to minimize the use and adverse effects of opioids.

Case Report: A 62-year-old female with a squamous cell neoplasm of the ethmoid sinus scheduled for maxillectomy. A multimodal anesthetic approach was implemented, including the preemptive block of the trigeminal nerve branches. During resection, notable intraoperative hemodynamic stability was maintained, achieving an opioid-sparing effect and reducing sevoflurane requirements. The patient reported zero pain levels (VAS 0/10) during the first 24 postoperative hours, without presenting nausea, vomiting, or complications associated with opioid use.

Discussion: Regional anesthesia offers significant advantages in maxillofacial surgery. In this case, it allowed for effective pain control with minimal opioid utilization, thereby reducing side effects such as nausea, vomiting, and respiratory depression, as well as promoting an enhanced recovery

Conclusion: The trigeminal nerve block serves as a valuable strategy for the anesthesiologist in maxillectomy procedures, improving the patient's postoperative experience.

Recibido: 30/01/2024

Aprobado: 21/05/2026